Skip to content

IXI raises $36.5M funding to develop autofocus eyewear

IXI, a company which it says it is on a mission to change how the world sees with the first autofocus glasses, has raised 36.5 million USD in Series A funding. The round was led by Plural, with participation from Tesi, byFounders, Heartcore, Eurazeo, FOV Ventures, Tiny Supercomputer and IXI’s existi

IXI raises $36.5M funding to develop autofocus eyewear
Published: | 2 min read

IXI, a company which it says it is on a mission to change how the world sees with the first autofocus glasses, has raised 36.5 million USD in Series A funding. The round was led by Plural, with participation from Tesi, byFounders, Heartcore, Eurazeo, FOV Ventures, Tiny Supercomputer and IXI’s existing investors. The new funding will enable IXI to complete the product development of IXI Adaptive Eyewear and kick off the commercial operations.

Founded in 2021 by a pioneering team of wearable technology, optics and industrial design, IXI is disrupting the 200 billion USD eyewear market with dynamic lenses that automatically adapt to the wearer’s eyes. Its technology will provide a wider field of view in a product that works just as nature intended your eyes to work. IXI is creating a new category of eyewear, featuring unique real-time and ultra-low-power eye tracking and state-of-the-art dynamic lens technology. The result is an elegant design that redefines what advanced vision tech can look and feel like.

The company is on a mission to finally break the limits of traditional eyewear; limits which have remained in place for centuries. Traditional progressive lenses force wearers to compromise: narrow fields of view, peripheral distortion, and difficulty seeing clearly at varying distances are common trade-offs. As global populations age, presbyopia diagnoses increase and millions face significant compromises in multi-focal vision, turning an already widespread challenge into a looming global issue.

Niko Eiden, co-founder and CEO of IXI said: “Eyewear is the world’s oldest wearable, rooted in centuries of brilliance across science, design and craftsmanship. That being said, it’s incredible that we haven’t seen more technology leaps, leaving millions of people forced to compromise on how they see the world. The time for change is now. We’re creating a whole new era in vision tech—and we can’t wait to show the world what’s coming. Backed by investors who see the scale of this opportunity, we’re ready to redefine what eyewear can be.”

IXI’s founders, Niko Eiden (CEO) and Ville Miettinen (Chief Algorithm Officer) previously co-founded the premium mixed reality hardware startup, Varjo. Their experience in advanced optics and eye-tracking solutions inspired them to create a new kind of eyewear that truly solves the challenge of vision correction and liberates people from poor eyesight.


Sten Tamkivi, Partner at Plural said: “Niko, Ville and the team’s rare European hardware expertise puts them at the forefront of advanced optics and eye-tracking developments. They’re creating beautiful, literally invisible technology that pioneers a new approach to vision which will finally improve human eyesight once and for all. By backing IXI, we’re not just investing in a company, but in a future where technology revolutionises how we see the world.”

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information

More in Medical Device Manufacturing

See all

More from Oliver Johnson

See all
Holistic scientific frameworks for real-world use

Holistic scientific frameworks for real-world use

/

From our partners

Sponsored content
Driving innovation in medical motion control

Driving innovation in medical motion control

Whether it’s the smooth articulation of a surgical robot, the precise positioning of an imaging system, or the reliable, repeatable movement inside a laboratory instrument, motion control plays a key role in modern medical devices. Despite this, however, it is often one of the most complex aspects o

/